RenJi Hospital: clinical-trial pipeline

RenJi Hospital is the sponsor of 550 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 175 are not yet finished and 5 were first posted in the last 90 days. Source: Arcadium Data, data as of .

Open trials175
Phase 2/3 and 328
Countries1
New in 90 days5

Trials by phase

PhaseTrials
Not applicable397
Phase 254
Phase 442
Phase 317
Early phase 112
Phase 112
Phase 2/311
Phase 1/25

Trials by status

StatusTrials
Unknown268
Completed101
Recruiting92
Not yet recruiting71
Active, not recruiting12
Terminated3
Withdrawn or not authorised2
Suspended or halted1

Condition areas

AreaTrials
Oncology195
Cardiovascular110
Nephrology and urology104
Gastroenterology and liver92
Immunology and rheumatology62
Metabolic and endocrine (diabetes, obesity)28
Neurology25
Musculoskeletal24
Rare and genetic diseases23
Infectious disease and vaccines19
Respiratory17
Women's health and obstetrics14

Countries

CountryTrials
China452

Latest changes

DayChangeTrial
2026-10-23New trial postedGBP-213 in Patients With Autosomal Dominant Polycystic Kidney Disease
2026-10-15New trial postedPlasma DNA Methylation for Preoperative Classification of Renal Masses
2026-10-02New trial postedEffect of Remimazolam on Hypoxemia and/or Hypotension in Prostate Biopsy
2026-09-22New trial postedLong-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012…
2026-09-10New trial postedDual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Open trials

The 25 most recently changed open trials.

Registry idTitlePhaseStatusCountries
NCT05926726GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular CarcinomaNot applicableRecruitingChina
NCT05416684Prospective Observational Study on Comprehensive Effects of PEEK Cranioplasty and Titanium Cranioplasty After…Not applicableRecruitingChina
NCT05851677Disitamab Vedotin (RC48-ADC) in Breast CancerNot applicableRecruitingChina
NCT07740408OCT in Endovascular Recanalization of Chronic Carotid Artery OcclusionNot applicableActive, not recruitingChina
NCT06478225Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Canc…Not applicableRecruitingChina
NCT06124768Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Th…Not applicableRecruitingChina
NCT07622199PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for A…Not applicableRecruitingChina
NCT06653465Intravenous Acetaminophen for Postoperative Delirium in Older Patients Recovering From Major Noncardiac Surge…Phase 2/3Not yet recruiting
NCT06652906Study on the Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in People Aged 50 to 7…Phase 2RecruitingChina
NCT06511349Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)Early phase 1RecruitingChina
NCT07157631Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA TrialNot applicableRecruitingChina
NCT07335900A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic S…Not applicableRecruitingChina
NCT06851663Trop2-targeted immunoPET Imaging of Solid TumorsPhase 2/3RecruitingChina
NCT07755592miRNA Panel for PCa DiagnosisNot applicableRecruitingChina
NCT07343076Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Dise…Not applicableNot yet recruiting
NCT06391320Obesity Queue DatabaseNot applicableRecruitingChina
NCT06301438Dalpiciclib in HR+/HER2- ABCNot applicableRecruitingChina
NCT05727722Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure AdultsPhase 1RecruitingChina
NCT05810142Clinical Study on Third-line Treatment of Advanced Duodenal Adenocarcinoma by Fuquinitinib Combined With Sind…Not applicableNot yet recruiting
NCT07678645The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis Wi…Phase 2Not yet recruitingChina
NCT06978933FGF19 Overexpression Combination Unified Study in HCC-19Phase 2RecruitingChina
NCT06645275Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurren…Phase 4Not yet recruiting
NCT06002711Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gli…Not applicableRecruitingChina
NCT06793969Swartz Sheath With Angioplasty Guidewire-Assisted Technique for Patent Foramen Ovale Closure (STAGE-PFO)Not applicableRecruitingChina
NCT06931223Efficacy of Gut-Brain Neuromodulators for Functional DyspepsiaNot applicableNot yet recruiting

All sponsors: clinical-trial pipeline by sponsor.

Track a sponsor's pipeline

The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.

Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.

Cite as: Arcadium Data, "RenJi Hospital clinical trials: 175 open, 28 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/renji-hospital/, data as of 2026-10-25.